Lavillonnière Flore, Chajès Véronique, Martin Jean-Charles, Sébédio Jean-Louis, Lhuillery Claude, Bougnoux Philippe
Nutrition, Croissance et Cancer, INSERM E 0211, IFR 120, Université François-Rabelais, 2 bis Boulevard Tonnellé, F-37044 Tours, France.
Nutr Cancer. 2003;45(2):190-4. doi: 10.1207/S15327914NC4502_08.
To determine whether the purified 9c,11t conjugated linoleic acid (CLA) isomer, the main dietary isomer, is biologically active on mammary tumor growth, we carried out a dietary intervention study designed to compare its effects with those of a mixture of CLA isomers on the incidence and growth of autochthonous mammary tumors induced by methylnitrosourea in rats. After the initiation step, rats were fed a sunflower oil-based diet (5%) and separated into three experimental groups supplemented with either a 1% homemade synthesized 9c,11t isomer, a 1% CLA isomer mixture, or free fatty acids prepared from sunflower oil for the control group. We found that, in the two CLA groups compared with the control group, CLA levels were about 30 times higher in mammary fat pads and about 10 times higher in tumor tissues. Compared with the control group, there was a 44% and 45% decrease in tumor mass per rat in the CLA mixture and the 9c,11t groups, respectively, at 20 wk of diet (P < 0.05). There was a nonsignificant trend for a decrease multiplicity in CLA groups compared with the control group, with a 30% and 35% decrease in the CLA mixture and the 9c,11t groups, respectively. Incidence and latency were not significantly different between the dietary groups. Although the effect was specifically restricted in reduction in tumor mass, we concluded that the main CLA isomer found in human diet has anticarcinogenic properties in experimental mammary carcinogenesis.
为了确定纯化的9c,11t共轭亚油酸(CLA)异构体(主要的膳食异构体)对乳腺肿瘤生长是否具有生物活性,我们开展了一项膳食干预研究,旨在比较其与CLA异构体混合物对甲基亚硝基脲诱导的大鼠自发性乳腺肿瘤的发生率和生长的影响。在启动阶段后,给大鼠喂食基于葵花籽油的饮食(5%),并将其分为三个实验组,分别补充1%的自制合成9c,11t异构体、1%的CLA异构体混合物,对照组则补充从葵花籽油中制备的游离脂肪酸。我们发现,与对照组相比,在两个CLA组中,乳腺脂肪垫中的CLA水平高出约30倍,肿瘤组织中的CLA水平高出约10倍。与对照组相比,在饮食20周时,CLA混合物组和9c,11t组每只大鼠的肿瘤质量分别下降了44%和45%(P < 0.05)。与对照组相比,CLA组的肿瘤多发性有下降的趋势,但不显著,CLA混合物组和9c,11t组分别下降了30%和35%。各饮食组之间的发病率和潜伏期没有显著差异。尽管这种作用具体仅限于肿瘤质量的降低,但我们得出结论,在人类饮食中发现的主要CLA异构体在实验性乳腺致癌过程中具有抗癌特性。